Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-05-05

Clinical Trial Update: Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation for Type 1 Diabetes With Diabetic Ketoacidosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating allogeneic umbilical cord mesenchymal stem cell transplantation for Type 1 diabetes with diabetic ketoacidosis; current status is unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allogeneic Umbilical Cord Mesenchymal Stem Cells (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Ketoacidosis, Diabetic | Phase 2 | Status: UNKNOWN